Charles Webb
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
-
- Antibiotic Use and Resistance
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Advanced Breast Cancer Therapies 3
- Oncology 10
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 3
- Co-authors
- W. Michael Scheld (1 shared paper)A. Dine (1 shared paper)Peter G. Pappas (1 shared paper)Charles M. van der Horst (1 shared paper)Adolf W. Karchmer (1 shared paper)Marcia J. Levenstein (1 shared paper)John Rex (1 shared paper)Ronald G. Washburn (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Diagnostic Microbiology and Infectious Disease (4 papers)Clinical Infectious Diseases (2 papers)Cancer Investigation (2 papers)Southern Journal of Applied Forestry (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Charles Webb
29 papers receiving 1.1k citations
Charles Webb's Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 694
- Applied Microbiology and Biotechnology 62
- Epidemiology 485
- Clinical Biochemistry 80
- Critical Care and Intensive Care Medicine 47
Countries citing papers authored by Charles Webb
This map shows the geographic impact of Charles Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Webb more than expected).
Fields of papers citing papers by Charles Webb
This network shows the impact of papers produced by Charles Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Webb. The network helps show where Charles Webb may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Webb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia Hit paper breakdown → | 1994 | 788 |
| 2 | 1992 | 81 | |
| 3 | 1993 | 54 | |
| 4 | A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer. | 2012 | 42 |
| 5 | 2002 | 34 | |
| 6 | 2009 | 28 | |
| 7 | 2013 | 19 | |
| 8 | 2002 | 15 | |
| 9 | 2009 | 15 | |
| 10 | 2000 | 15 | |
| 11 | 2002 | 13 | |
| 12 | 2012 | 12 | |
| 13 | 2004 | 12 | |
| 14 | 2007 | 10 | |
| 15 | 2010 | 10 | |
| 16 | 1960 | 7 | |
| 17 | 2002 | 6 | |
| 18 | Sycamore Seed Germination: The Effects of Provenance, Stratification, Temperature, and Parent Tree | 1968 | 6 |
| 19 | 2017 | 6 | |
| 20 | 2011 | 5 |
About Charles Webb
Charles Webb is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Epidemiology and Surgery, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (7 papers), Pneumonia and Respiratory Infections (4 papers), Bacterial Infections and Vaccines (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Infectious Diseases (694 citations), Applied Microbiology and Biotechnology (62 citations), Epidemiology (485 citations), Clinical Biochemistry (80 citations) and Critical Care and Intensive Care Medicine (47 citations). Charles Webb has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include W. Michael Scheld, A. Dine, Peter G. Pappas, Charles M. van der Horst, Adolf W. Karchmer, Marcia J. Levenstein, John Rex, Ronald G. Washburn, Alan M. Sugar and John E. Bennett. Their work appears in journals such as Journal of Clinical Oncology, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, Cancer Investigation and Southern Journal of Applied Forestry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.